Yonghe Medical Group Co., Ltd.

Equities

2279

KYG5688E1008

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
1.16 HKD +3.57% Intraday chart for Yonghe Medical Group Co., Ltd. +7.41% -54.15%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Yonghe Medical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Yonghe Medical to Widen Loss in 2023 MT
Yonghe Medical Group Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2023 CI
Yonghe Medical Group Co., Ltd. commences an Equity Buyback for 52,708,041 shares, representing 10% of its issued share capital, under the authorization approved on June 16, 2023. CI
Yonghe Medical Group Shares Surge 17% on Share Buyback Plan MT
Yonghe Medical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Yonghe Medical to Swing to Loss in H1 MT
Yonghe Medical Group Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 CI
Yonghe Medical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Yonghe Medical Group Warns of 2022 Net Loss MT
Yonghe Medical Group Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2022 CI
Certain Ordinary Shares of Yonghe Medical Group Co., Ltd. are subject to a Lock-Up Agreement Ending on 12-DEC-2022. CI
Yonghe Medical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Yonghe Medical Group Co., Ltd. Announces Change of Joint Company Secretary, Authorised Representative and Process Agent CI
Yonghe Medical Group Co., Ltd. Announces Change of Address of Principal Place of Business in Hong Kong CI
Yonghe Medical Warns of Lower H1 Profit on COVID Hit MT
Yonghe Medical Group Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022 CI
Yonghe Medical Group Co., Ltd. Approves to Declare Final Dividend for the Year Ended December 31, 2021 CI
Yonghe Medical Group Co., Ltd. Announces Director Appointments CI
Yonghe Medical Group Co., Ltd.(SEHK:2279) added to S&P Global BMI Index CI
Certain Ordinary Shares of Yonghe Medical Group Co., Ltd. are subject to a Lock-Up Agreement Ending on 12-JUN-2022. CI
Yonghe Medical Group Co., Ltd. Announces Executive Changes CI
Yonghe Medical Group Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2021 CI
Yonghe Medical Group Co., Ltd. Announces Change of Registered Address CI
Yonghe Medical Group Co., Ltd. Proposes Final Cash Dividend for the Year Ended December 31, 2021, Payable on September 20, 2022 CI
Chart Yonghe Medical Group Co., Ltd.
More charts
Yonghe Medical Group Co Ltd is a China-based company mainly engaged in hair transplant business. The Company's main business is to provide one-stop hair medical services through medical institutions, including hair transplantation, medical care, routine care and other ancillary services. The Company also provides hair repair products and scalp cleaning services.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
1.16 HKD
Average target price
2.4 HKD
Spread / Average Target
+106.90%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2279 Stock
  4. News Yonghe Medical Group Co., Ltd.
  5. Yonghe Medical Warns of Lower H1 Profit on COVID Hit